A cytomegalovirus-encoded lncRNA blocks cell-cycle progression
Molecular Cell · 2026
DOI: 10.1016/j.molcel.2026.02.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Tal Fisher und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. Hauptthemen laut MEDLINE: Cytomegalovirus, RNA, Viral, RNA, Long Noncoding, Cytomegalovirus Infections. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Israel Science Foundation, H2020 European Research Council.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel.
- Department of Virology, Kimron Veterinary Institute, Bet Dagan 50250, Israel.
- Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 76100, Israel. Electronic address: noam.stern-ginossar@weizmann.ac.il.
Förderung
- Israel Science Foundation
- H2020 European Research Council
Zitieren
APA
Fisher, T., Mizrahi, O., Tai-Schmiedel, J., Nachshon, A., Schwartz, M., Patrick, M., Gluck, A., Aharon, E., Karniely, S., & Stern-Ginossar, N. (2026). A cytomegalovirus-encoded lncRNA blocks cell-cycle progression. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.02.025
Vancouver
Fisher T, Mizrahi O, Tai-Schmiedel J, Nachshon A, Schwartz M, Patrick M, et al. A cytomegalovirus-encoded lncRNA blocks cell-cycle progression. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.02.025
BibTeX
@article{Fisher2026,
author = {Fisher, Tal and Mizrahi, Orel and Tai-Schmiedel, Julie and Nachshon, Aharon and Schwartz, Michal and Patrick, Meidva and Gluck, Avraham and Aharon, Einav and Karniely, Sharon and Stern-Ginossar, Noam},
title = {A cytomegalovirus-encoded lncRNA blocks cell-cycle progression},
journal = {Molecular Cell},
year = {2026},
doi = {10.1016/j.molcel.2026.02.025}
}
EUVIMED